Range
5.47 - 5.81
Vol / Avg.
23.7K/203.6K
Div / Yield
-
52 Wk
5.29 - 37.86
Mkt Cap
147.9M
Payout Ratio
-
Open
5.67
P/E
-
EPS
-0.65
Shares
25.8M
Outstanding
25.8M
Total Float
17.5M
Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients. The company is in the process of developing intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. Its pipeline product includes ONCR-177; ONCR-GBM; Coxsackievirus A21 and Seneca Valley Virus.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS-0.640-0.650 -0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Oncorus Questions & Anwsers

Q

How do I buy Oncorus (ONCR) stock?

A

You can purchase shares of Oncorus (NASDAQ: ONCR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Oncorus's (ONCR) competitors?

A

There are no as such competitors for Oncorus.

Q

What is the target price for Oncorus (ONCR) stock?

A

The latest price target for Oncorus (NASDAQ: ONCR) was reported by Maxim Group on March 16, 2021. The analyst firm set a price target for 35.00 expecting ONCR to rise to within 12 months (a possible 510.82% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Oncorus (ONCR)?

A

The stock price for Oncorus (NASDAQ: ONCR) is $5.73 last updated Today at 3:24:30 PM.

Q

Does Oncorus (ONCR) pay a dividend?

A

There are no upcoming dividends for Oncorus.

Q

When is Oncorus (NASDAQ:ONCR) reporting earnings?

A

Oncorus’s $Q3 earnings are confirmed for after-market on November 3, 2021.

Q

Is Oncorus (ONCR) going to split?

A

There is no upcoming split for Oncorus.

Q

What sector and industry does Oncorus (ONCR) operate in?

A

Oncorus is in the sector and industry. They are listed on the NASDAQ.